ArticleScientific reports2026
A lightweight CNN for enhanced non-small cell lung cancer classification using CT scan image.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Lung cancer is a leading cause of cancer-related mortality worldwide, and its early and accurate detection is critical for improving patient outcomes. Computed tomography (CT) scans are widely used to diagnose lung cancer; however, the accuracy of diagnosis often depends on the expertise of radiologists. Recently, deep learning-based clinical decision support systems have shown promise in assisting diagnosis by providing reliable and consistent predictions. In this paper, we propose MiniConvNet, a lightweight convolutional neural network designed to detect and classify non-small cell lung cancer (NSCLC) and its subtypes, adenocarcinoma, squamous cell carcinoma, and large cell carcinoma, from CT images. We also evaluate the model's generalizability on a histopathological lung cancer dataset, demonstrating its robustness across imaging modalities. We benchmark MiniConvNet against several established CNN architectures, including ResNet50, VGG16, VGG19, Inception V3, MobileNetV3Small, EfficientNetV2B0, and ConvNeXtTiny, under identical experimental conditions. Extensive experiments on two publicly available datasets show that MiniConvNet achieves competitive or superior performance compared to the baselines while maintaining a significantly smaller model size and faster inference. These results highlight MiniConvNet's potential as an efficient and deployable tool for lung cancer subtype classification in resource-constrained clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.